biocon: Biocon acquires Eywa Pharma’s US-based plant for $7.7 million
Biotechnology major Biocon on Saturday said its unit has acquired Eywa Pharma Inc's oral solid dosage manufacturing facility in the US for $7.7 million (over Rs 63 crore). Biocon ...
